HPM Partners »

Xeris Pharmaceuticals shares owned by HPM Partners

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by HPM Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $43k 15k 2.85

More positions owned by HPM Partners

Vanguard Index Fds Etf (VOO)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Spdr S&p 500 Etf Tr Etf (SPY)
Procter And Gamble Stock (PG)
NVIDIA Corporation (NVDA)
Ishares Tr Etf (IVV)
Vanguard Tax-managed Fds Stock (VEA)
Ishares Tr Etf (IEFA)
Amazon Stock (AMZN)
Eli Lilly & Co Stock (LLY)
Ishares Tr Stock (AGG)
Ishares Tr Stock (QUAL)
Alphabet Stock (GOOGL)
Facebook Inc cl a (META)

View all positions for HPM Partners

Top funds holding Xeris Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
CenterBook Partners
Geode Capital Management
State Street Corporation
Rosalind Advisors
AIGH Capital Management
Morgan Stanley
Renaissance Technologies
Nuveen Asset Management
Northern Trust
AQR Capital Management
Redmile Group

View all funds holding Xeris Pharmaceuticals